Insider Transactions in Q1 2023 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2023
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
307
-1.15%
|
$41,752
$136.66 P/Share
|
|
Mar 08
2023
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
314
-1.16%
|
$48,042
$153.19 P/Share
|
|
Mar 08
2023
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
635
-2.2%
|
$97,155
$153.19 P/Share
|
|
Mar 08
2023
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
744
-2.1%
|
$113,832
$153.19 P/Share
|
|
Mar 08
2023
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.28%
|
$139,536
$153.19 P/Share
|
|
Mar 06
2023
|
Stephen Mayo |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+16.15%
|
-
|
|
Mar 06
2023
|
Claude Nicaise |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+8.53%
|
-
|
|
Mar 06
2023
|
Kathryn Jean Boor |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+19.15%
|
-
|
|
Mar 06
2023
|
Michael Andrew Chambers |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+19.15%
|
-
|
|
Mar 06
2023
|
Ryan Edward Brown EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+13.51%
|
-
|
|
Mar 06
2023
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,325
-2.6%
|
$208,025
$157.21 P/Share
|
|
Mar 06
2023
|
Richard Barry |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+0.05%
|
-
|
|
Mar 06
2023
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+5.95%
|
-
|
|
Mar 06
2023
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,134
-1.67%
|
$178,038
$157.21 P/Share
|
|
Mar 06
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+0.94%
|
-
|
|
Mar 06
2023
|
Ian Michael Estepan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+11.27%
|
-
|
|
Mar 06
2023
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,370
-4.24%
|
$215,090
$157.21 P/Share
|
|
Mar 06
2023
|
Bilal Arif Chief Tech Ops Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+14.29%
|
-
|
|
Mar 06
2023
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-0.75%
|
$53,380
$157.21 P/Share
|
|
Mar 06
2023
|
Hans Lennart Rudolf Wigzell |
BUY
Grant, award, or other acquisition
|
Direct |
1,523
+6.76%
|
-
|
|
Mar 01
2023
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-0.77%
|
$76,734
$147.57 P/Share
|
|
Mar 01
2023
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
378
-1.16%
|
$55,566
$147.57 P/Share
|
|
Mar 01
2023
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.76%
|
$28,812
$147.57 P/Share
|
|
Mar 01
2023
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.55%
|
$37,044
$147.57 P/Share
|